(Q80088629)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404540%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

[Markers of thrombotic disease: procoagulant microparticles] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404540%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

O Morel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404540%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

F Toti

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404540%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

J-M Freyssinet

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404540%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404540%20AND%20SRC:MED&resulttype=core&format=json

Annales pharmaceutiques françaises

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404540%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404540%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404540%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

75-84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404540%20AND%20SRC:MED&resulttype=core&format=json

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Prevalence of conventional risk factors in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Cellular microparticles: what are they bad or good for?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Membrane microparticles: two sides of the coin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Cellular microparticles: a disseminated storage pool of bioactive vascular effectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Activated protein C induces the release of microparticle-associated endothelial protein C receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Eptifibatide-induced thrombocytopenia and circulating procoagulant platelet-derived microparticles in a patient with acute coronary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Microparticles in cardiovascular diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Shed Membrane Microparticles With Procoagulant Potential in Human Atherosclerotic Plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Platelet microparticles induce angiogenesis in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: A novel vascular redox pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Endothelium-derived microparticles impair endothelial function in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Shed membrane microparticles from circulating and vascular cells in regulating vascular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Type 1 and type 2 diabetic patients display different patterns of cellular microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

P-selectin and leukocyte microparticles are associated with venous thrombogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Systemic inflammation and disseminated intravascular coagulation in early stage of ALI and ARDS: role of neutrophil and endothelial activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Increased level of oxidized LDL-dependent monocyte-derived microparticles in acute coronary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

High levels of circulating endothelial microparticles in patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Injection of recombinant activated factor VII can induce transient increase in circulating procoagulant microparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Aggregates of endothelial microparticles and platelets circulate in peripheral blood. Variations during stable coronary disease and acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Protective effects of vitamin C on endothelium damage and platelet activation during myocardial infarction in patients with sustained generation of circulating microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

P-selectin and platelet-derived microparticles associated with monocyte activation markers in patients with pulmonary embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Effect of ticlopidine on monocyte-derived microparticles and activated platelet markers in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Vitamin C inhibits endothelial cell apoptosis in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Effects of losartan and simvastatin on monocyte-derived microparticles in hypertensive patients with and without type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Effect of bezafibrate on soluble adhesion molecules and platelet activation markers in patients with connective tissue diseases and secondary hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

Circulating cell-derived microparticles in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990020-6

10.1016/S0003-4509(07)90020-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404540%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference